John Bernard Payne, Director at Zivo Bioscience, Inc. (ZIVO), bought 9,168 shares at $2.50 ($23K) on 2022-01-25, disclosed to the SEC on 2022-01-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.50 | 9,122 | $23K | 99.5% |
| 2 | $2.50 | 46 | $115 | 0.5% |
| Total | $2.50 avg | 9,168 | $23K | 100% |
| Filing → |
| ZIVO | BUY | 2022-12-20 | $143 | — | Filing → |